EO 104 imposed price reductions on essential drugs prescribed for leading diseases as Hypertension, Diabetes, Heart Disease, Chronic Lung Diseases and Major Cancers.  

True to its commitment to put patients at the heart of its actions, Servier Philippines had to absorb the cost burden of 40-65% price reduction imposed on its specific hypertension and CAD product lines.  Effective June 2020, Coralan , Triplixam, and Viacoram Initio are already available at significantly reduced retail prices.